Cancer Gene Therapy Market Size, Trends, Analysis, and Outlook By Therapy (Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer), By End-User (Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Others), by Region, Country, Segment, and Companies, 2024-2030
The global Cancer Gene Therapy market size is poised to register 20.3% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Cancer Gene Therapy market across By Therapy (Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer), By End-User (Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Others).
The Cancer Gene Therapy Market is experiencing notable growth and therapeutic innovation in 2024 and beyond, driven by advancements in gene editing technologies, viral vector delivery systems, and targeted gene manipulation approaches aimed at correcting genetic mutations, disrupting oncogenic pathways, and inducing tumor cell death in cancer patients with genetic predispositions, hereditary cancer syndromes, or acquired genetic alterations associated with tumorigenesis, tumor progression, and treatment resistance mechanisms. Cancer gene therapy encompasses a diverse range of therapeutic strategies, including gene replacement therapy, gene silencing therapy, suicide gene therapy, and adoptive cell transfer therapy, designed to modulate cancer cell biology, enhance antitumor immunity, and improve treatment outcomes through precise genetic modifications and molecular interventions that target specific genes, signaling pathways, and cellular functions implicated in cancer development and progression. Key trends include the development of innovative gene editing tools, such as CRISPR-Cas9, zinc finger nucleases (ZFNs), and transcription activator-like effector nucleases (TALENs), for precise genome engineering and targeted gene editing in cancer cells, as well as the exploration of novel gene delivery platforms, viral vectors, and nonviral nanoparticles for efficient gene transfer, transduction, and expression in tumor tissues while minimizing off-target effects, immune responses, and vector-related toxicities. Additionally, there is a growing emphasis on personalized gene therapy approaches, patient-specific gene editing strategies, and ex vivo gene modification techniques that tailor cancer treatments to individual genetic profiles, tumor molecular subtypes, and immunogenomic characteristics, as well as a growing focus on regulatory oversight, ethical considerations, and long-term safety monitoring in gene therapy clinical trials and translational research programs to ensure patient safety, treatment efficacy, and ethical integrity in gene-based cancer therapies. Moreover, collaborative partnerships between gene therapy companies, academic medical centers, and patient advocacy organizations are essential for advancing cancer gene therapy research, fostering innovation, and translating scientific discoveries into transformative gene-based cancer treatments that improve patient outcomes and quality of life in oncology practice worldwide.
Cancer Gene Therapy Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Cancer Gene Therapy market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Cancer Gene Therapy survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Cancer Gene Therapy industry.
Key market trends defining the global Cancer Gene Therapy demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Cancer Gene Therapy Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Cancer Gene Therapy industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Cancer Gene Therapy companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Cancer Gene Therapy industry
Leading Cancer Gene Therapy companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Cancer Gene Therapy companies.
Cancer Gene Therapy Market Study- Strategic Analysis Review
The Cancer Gene Therapy market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Cancer Gene Therapy industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Cancer Gene Therapy Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Cancer Gene Therapy Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Cancer Gene Therapy market segments. Similarly, Strong end-user demand is encouraging Canadian Cancer Gene Therapy companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Cancer Gene Therapy market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Cancer Gene Therapy Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Cancer Gene Therapy industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Cancer Gene Therapy market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Cancer Gene Therapy Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Cancer Gene Therapy in Asia Pacific. In particular, China, India, and South East Asian Cancer Gene Therapy markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Cancer Gene Therapy Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Cancer Gene Therapy Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Cancer Gene Therapy market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Cancer Gene Therapy.
Cancer Gene Therapy Market Company Profiles
The global Cancer Gene Therapy market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abeona Therapeutics Inc, Altor Bioscience Inc, Asklepios BioPharmaceutical Inc, BioCancell Inc, Bluebird bio Inc, CelgeneInc, Elevate BioInc, Genelux Corp, GenVec, GlaxoSmithKlineInc, Introgen TherapeuticsInc, MerckKGaA, OncoGenex Pharmaceuticals Inc
Recent Cancer Gene Therapy Market Developments
The global Cancer Gene Therapy market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Cancer Gene Therapy Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Therapy
Oncolytic Virotherapy
Gene Induced Immunotherapy
Gene Transfer
By End-user
Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Others
Geographical Segmentation:
Abeona Therapeutics Inc
Altor Bioscience Inc
Asklepios BioPharmaceutical Inc
BioCancell Inc
Bluebird bio Inc
CelgeneInc
Elevate BioInc
Genelux Corp
GenVec
GlaxoSmithKlineInc
Introgen TherapeuticsInc
MerckKGaA
OncoGenex Pharmaceuticals Inc
Formats Available: Excel, PDF, and PPT
The Cancer Gene Therapy Market is experiencing notable growth and therapeutic innovation in 2024 and beyond, driven by advancements in gene editing technologies, viral vector delivery systems, and targeted gene manipulation approaches aimed at correcting genetic mutations, disrupting oncogenic pathways, and inducing tumor cell death in cancer patients with genetic predispositions, hereditary cancer syndromes, or acquired genetic alterations associated with tumorigenesis, tumor progression, and treatment resistance mechanisms. Cancer gene therapy encompasses a diverse range of therapeutic strategies, including gene replacement therapy, gene silencing therapy, suicide gene therapy, and adoptive cell transfer therapy, designed to modulate cancer cell biology, enhance antitumor immunity, and improve treatment outcomes through precise genetic modifications and molecular interventions that target specific genes, signaling pathways, and cellular functions implicated in cancer development and progression. Key trends include the development of innovative gene editing tools, such as CRISPR-Cas9, zinc finger nucleases (ZFNs), and transcription activator-like effector nucleases (TALENs), for precise genome engineering and targeted gene editing in cancer cells, as well as the exploration of novel gene delivery platforms, viral vectors, and nonviral nanoparticles for efficient gene transfer, transduction, and expression in tumor tissues while minimizing off-target effects, immune responses, and vector-related toxicities. Additionally, there is a growing emphasis on personalized gene therapy approaches, patient-specific gene editing strategies, and ex vivo gene modification techniques that tailor cancer treatments to individual genetic profiles, tumor molecular subtypes, and immunogenomic characteristics, as well as a growing focus on regulatory oversight, ethical considerations, and long-term safety monitoring in gene therapy clinical trials and translational research programs to ensure patient safety, treatment efficacy, and ethical integrity in gene-based cancer therapies. Moreover, collaborative partnerships between gene therapy companies, academic medical centers, and patient advocacy organizations are essential for advancing cancer gene therapy research, fostering innovation, and translating scientific discoveries into transformative gene-based cancer treatments that improve patient outcomes and quality of life in oncology practice worldwide.
Cancer Gene Therapy Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Cancer Gene Therapy market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Cancer Gene Therapy survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Cancer Gene Therapy industry.
Key market trends defining the global Cancer Gene Therapy demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Cancer Gene Therapy Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Cancer Gene Therapy industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Cancer Gene Therapy companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Cancer Gene Therapy industry
Leading Cancer Gene Therapy companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Cancer Gene Therapy companies.
Cancer Gene Therapy Market Study- Strategic Analysis Review
The Cancer Gene Therapy market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Cancer Gene Therapy industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Cancer Gene Therapy Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Cancer Gene Therapy Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Cancer Gene Therapy market segments. Similarly, Strong end-user demand is encouraging Canadian Cancer Gene Therapy companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Cancer Gene Therapy market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Cancer Gene Therapy Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Cancer Gene Therapy industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Cancer Gene Therapy market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Cancer Gene Therapy Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Cancer Gene Therapy in Asia Pacific. In particular, China, India, and South East Asian Cancer Gene Therapy markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Cancer Gene Therapy Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Cancer Gene Therapy Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Cancer Gene Therapy market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Cancer Gene Therapy.
Cancer Gene Therapy Market Company Profiles
The global Cancer Gene Therapy market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abeona Therapeutics Inc, Altor Bioscience Inc, Asklepios BioPharmaceutical Inc, BioCancell Inc, Bluebird bio Inc, CelgeneInc, Elevate BioInc, Genelux Corp, GenVec, GlaxoSmithKlineInc, Introgen TherapeuticsInc, MerckKGaA, OncoGenex Pharmaceuticals Inc
Recent Cancer Gene Therapy Market Developments
The global Cancer Gene Therapy market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Cancer Gene Therapy Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Therapy
Oncolytic Virotherapy
Gene Induced Immunotherapy
Gene Transfer
By End-user
Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Abeona Therapeutics Inc
Altor Bioscience Inc
Asklepios BioPharmaceutical Inc
BioCancell Inc
Bluebird bio Inc
CelgeneInc
Elevate BioInc
Genelux Corp
GenVec
GlaxoSmithKlineInc
Introgen TherapeuticsInc
MerckKGaA
OncoGenex Pharmaceuticals Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Cancer Gene Therapy Market Overview and Key Findings, 2024
1.2 Cancer Gene Therapy Market Size and Growth Outlook, 2021- 2030
1.3 Cancer Gene Therapy Market Growth Opportunities to 2030
1.4 Key Cancer Gene Therapy Market Trends and Challenges
1.4.1 Cancer Gene Therapy Market Drivers and Trends
1.4.2 Cancer Gene Therapy Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Cancer Gene Therapy Companies
2. CANCER GENE THERAPY MARKET SIZE OUTLOOK TO 2030
2.1 Cancer Gene Therapy Market Size Outlook, USD Million, 2021- 2030
2.2 Cancer Gene Therapy Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. CANCER GENE THERAPY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. CANCER GENE THERAPY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Therapy
Oncolytic Virotherapy
Gene Induced Immunotherapy
Gene Transfer
By End-user
Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Cancer Gene Therapy Market, 2025
5.2 Asia Pacific Cancer Gene Therapy Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Cancer Gene Therapy Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Cancer Gene Therapy Market, 2025
5.5 Europe Cancer Gene Therapy Market Size Outlook by Type, 2021- 2030
5.6 Europe Cancer Gene Therapy Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Cancer Gene Therapy Market, 2025
5.8 North America Cancer Gene Therapy Market Size Outlook by Type, 2021- 2030
5.9 North America Cancer Gene Therapy Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Cancer Gene Therapy Market, 2025
5.11 South America Pacific Cancer Gene Therapy Market Size Outlook by Type, 2021- 2030
5.12 South America Cancer Gene Therapy Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Cancer Gene Therapy Market, 2025
5.14 Middle East Africa Cancer Gene Therapy Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Cancer Gene Therapy Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Cancer Gene Therapy Market Size Outlook and Revenue Growth Forecasts
6.2 US Cancer Gene Therapy Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Cancer Gene Therapy Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Cancer Gene Therapy Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Cancer Gene Therapy Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Cancer Gene Therapy Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Cancer Gene Therapy Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Cancer Gene Therapy Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Cancer Gene Therapy Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Cancer Gene Therapy Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Cancer Gene Therapy Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Cancer Gene Therapy Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Cancer Gene Therapy Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Cancer Gene Therapy Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Cancer Gene Therapy Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Cancer Gene Therapy Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Cancer Gene Therapy Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Cancer Gene Therapy Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Cancer Gene Therapy Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Cancer Gene Therapy Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Cancer Gene Therapy Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Cancer Gene Therapy Industry Drivers and Opportunities
7. CANCER GENE THERAPY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. CANCER GENE THERAPY COMPANY PROFILES
8.1 Profiles of Leading Cancer Gene Therapy Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abeona Therapeutics Inc
Altor Bioscience Inc
Asklepios BioPharmaceutical Inc
BioCancell Inc
Bluebird bio Inc
CelgeneInc
Elevate BioInc
Genelux Corp
GenVec
GlaxoSmithKlineInc
Introgen TherapeuticsInc
MerckKGaA
OncoGenex Pharmaceuticals Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Cancer Gene Therapy Market Overview and Key Findings, 2024
1.2 Cancer Gene Therapy Market Size and Growth Outlook, 2021- 2030
1.3 Cancer Gene Therapy Market Growth Opportunities to 2030
1.4 Key Cancer Gene Therapy Market Trends and Challenges
1.4.1 Cancer Gene Therapy Market Drivers and Trends
1.4.2 Cancer Gene Therapy Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Cancer Gene Therapy Companies
2. CANCER GENE THERAPY MARKET SIZE OUTLOOK TO 2030
2.1 Cancer Gene Therapy Market Size Outlook, USD Million, 2021- 2030
2.2 Cancer Gene Therapy Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. CANCER GENE THERAPY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. CANCER GENE THERAPY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Therapy
Oncolytic Virotherapy
Gene Induced Immunotherapy
Gene Transfer
By End-user
Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Cancer Gene Therapy Market, 2025
5.2 Asia Pacific Cancer Gene Therapy Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Cancer Gene Therapy Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Cancer Gene Therapy Market, 2025
5.5 Europe Cancer Gene Therapy Market Size Outlook by Type, 2021- 2030
5.6 Europe Cancer Gene Therapy Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Cancer Gene Therapy Market, 2025
5.8 North America Cancer Gene Therapy Market Size Outlook by Type, 2021- 2030
5.9 North America Cancer Gene Therapy Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Cancer Gene Therapy Market, 2025
5.11 South America Pacific Cancer Gene Therapy Market Size Outlook by Type, 2021- 2030
5.12 South America Cancer Gene Therapy Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Cancer Gene Therapy Market, 2025
5.14 Middle East Africa Cancer Gene Therapy Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Cancer Gene Therapy Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Cancer Gene Therapy Market Size Outlook and Revenue Growth Forecasts
6.2 US Cancer Gene Therapy Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Cancer Gene Therapy Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Cancer Gene Therapy Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Cancer Gene Therapy Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Cancer Gene Therapy Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Cancer Gene Therapy Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Cancer Gene Therapy Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Cancer Gene Therapy Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Cancer Gene Therapy Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Cancer Gene Therapy Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Cancer Gene Therapy Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Cancer Gene Therapy Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Cancer Gene Therapy Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Cancer Gene Therapy Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Cancer Gene Therapy Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Cancer Gene Therapy Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Cancer Gene Therapy Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Cancer Gene Therapy Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Cancer Gene Therapy Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Cancer Gene Therapy Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Cancer Gene Therapy Industry Drivers and Opportunities
7. CANCER GENE THERAPY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. CANCER GENE THERAPY COMPANY PROFILES
8.1 Profiles of Leading Cancer Gene Therapy Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abeona Therapeutics Inc
Altor Bioscience Inc
Asklepios BioPharmaceutical Inc
BioCancell Inc
Bluebird bio Inc
CelgeneInc
Elevate BioInc
Genelux Corp
GenVec
GlaxoSmithKlineInc
Introgen TherapeuticsInc
MerckKGaA
OncoGenex Pharmaceuticals Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
